Skip to content
Trial Eligibility
Menu

The Healthy Elderly Longevity Cohort

NCT01004133

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

With the completion of the human genome project, investigators can now explore new questions in human biology. Previously human genetics focused on highly penetrant, Mendelian traits; however, now rare and common variants can be discovered that affect "common" diseases that have multi-gene architecture with variable penetrance such as breast cancer, diabetes mellitus, and coronary artery disease.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Healthy

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
80 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Scripps Translational Science Institute
Last updated on ClinicalTrials.gov
January 17, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Scripps Translational Science Institute · La Jolla, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.